Literature DB >> 1909771

Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism.

D Piomelli1, C Pilon, B Giros, P Sokoloff, M P Martres, J C Schwartz.   

Abstract

Understanding the actions of the neurotransmitter dopamine in the brain is important in view of its roles in neuropsychiatric illnesses. Dopamine D1 receptors, which stimulate both adenylyl cyclase and phospholipase C, and D2 receptors, which inhibit them, can nevertheless act synergistically to produce many electrophysiological and behavioral responses. Because this functional synergism can occur at the level of single neurons, another, as yet unidentified, signalling pathway activated by dopamine has been hypothesized. We report here that in Chinese hamster ovary (CHO) cells transfected with the D2 receptor complementary DNA, D2 agonists potently enhanced arachidonic acid release, provided that such release has been initiated by stimulating constitutive purinergic receptors or by increasing intracellular Ca2+. In CHO cells expressed D1 receptors, D1 agonists exert no such effect. When D1 and D2 receptors are coexpressed, however, activation of both subtypes results in a marked synergistic potentiation of arachidonic acid release. The numerous actions of arachidonic acid and its metabolites in neuronal signal transduction suggest that facilitation of its release may be implicated in dopaminergic responses, such as feedback inhibition mediated by D2 autoreceptors, and may constitute a molecular basis for D1/D2 receptor synergism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909771     DOI: 10.1038/353164a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  49 in total

Review 1.  Dopamine receptor genes: new tools for molecular psychiatry.

Authors:  H B Niznik; H H Van Tol
Journal:  J Psychiatry Neurosci       Date:  1992-10       Impact factor: 6.186

Review 2.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

Review 3.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

4.  Arachidonic acid stimulates a novel cocaine-sensitive cation conductance associated with the human dopamine transporter.

Authors:  S L Ingram; S G Amara
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

5.  A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release.

Authors:  J Harvey; M G Lacey
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

6.  Expression of a G protein-coupled receptor (GPCR) leads to attenuation of signaling by other GPCRs: experimental evidence for a spontaneous GPCR constitutive inactive form.

Authors:  Maria Rosario Tubio; Natalia Fernandez; Carlos Patricio Fitzsimons; Sabrina Copsel; Sergio Santiago; Carina Shayo; Carlos Davio; Federico Monczor
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

7.  Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.

Authors:  J E Leysen; W Gommeren; J Mertens; W H Luyten; P J Pauwels; M Ewert; P Seeburg
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

Authors:  Richard B Mailman; Vishakantha Murthy
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

9.  A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids.

Authors:  M Fink; F Lesage; F Duprat; C Heurteaux; R Reyes; M Fosset; M Lazdunski
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

10.  Gabapentin's minimal action on markers of rat brain arachidonic acid metabolism agrees with its inefficacy against bipolar disorder.

Authors:  Edmund A Reese; Yewon Cheon; Epolia Ramadan; Hyung-Wook Kim; Lisa Chang; Jagadeesh S Rao; Stanley I Rapoport; Ameer Y Taha
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-07-27       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.